The Duke Cancer Institute
The Duke Cancer Institute brings together the extensive resources of Duke University, Duke Health, and the Duke Comprehensive Cancer Center. We are committed to making innovative discoveries, developing new ways to prevent, diagnose, and treat cancer, and delivering those therapies in a patient- and family-centric way.
Your Pancreatic Cancer Team
Our medical oncologists, radiation oncologists, surgical oncologists, and support team work together as a team and meet at least weekly to discuss challenging cases. Your personalized care is our goal.
Nutrition as Part of Your Treatment
Our dedicated nutritionist evaluates all new patients and offers counseling on diet and supplements to enhance your recovery. If you require surgery, our nutritionist will help you progress to normal eating and digestion as quickly as possible, a major hurdle for many people with pancreatic cancer.
High-Volume Whipple Center
This complex procedure requires high-level surgical skill and a knowledgeable staff, both of which you’ll find at Duke. Studies show that people who undergo a Whipple procedure in a major cancer center like ours experience fewer surgical complications, shorter hospital stays, and faster recovery.
Laparoscopic Whipple Experience
More than 100 laparoscopic Whipple procedures have been performed at Duke since we started doing this advanced, minimally invasive surgical procedure in 2010. Our experience has resulted in shorter operating times, less blood loss, and shorter hospital stays.
Leaders in Robotic Surgery
Duke surgeons perform thousands of robotic surgeries each year, including surgeries for pancreatic cancer. Robotic surgery leads to fewer complications, shorter hospital stays, and faster recovery times—meaning that you move on to the next phase of treatment or return to your activities more quickly. Our surgeons also advise industry engineers as they develop robotic surgical platforms that translate to better outcomes.
Nationally Recognized Experts
Our specialists are funded by the National Institutes of Health to study new ways to care for people with pancreatic cancer and precancerous lesions of the pancreas. Collectively, our findings have been published in more than 200 respected medical journals, including the New England Journal of Medicine. The Duke Cancer Institute is part of the National Comprehensive Cancer Network (NCCN), an alliance of the nation’s leading cancer centers dedicated to improving patient care.
As part of a National Cancer Institute-designated Comprehensive Cancer Center, our pancreatic cancer team is recognized for exploring new therapies through ongoing research and clinical trials. As a Duke patient, you may be eligible to participate in clinical trials that are testing new therapies before they become widely available.
Support for You and Your Family
Our comprehensive support services range from helping patients minimize the side effects of treatment to coping with the emotional and psychological effects of diagnosis and treatment. View all of our cancer support groups in our event calendar.